Guest guest Posted July 14, 2000 Report Share Posted July 14, 2000 In light of this animal study and related research, a recent proposal suggesting the mechanism that may occur within humans was outlined by Dr. Chamberlain. First, he proposed that a hypersecretion of B-endorphin from the hypothalamus resulted in a decreases release of ACTH from the pituitary which, in turn, caused a drop in the plasma concentrations of ACTH and cortisol. This pathway was proposed after consideration of an experiment by in 1983 where " ... systemic administration of B-endorphin [in humans] had been found to produce decreases in ACTH and cortisol plasma concentrations " (Chamberlain, 777). To this date, the role that these hormones play in relation to behavioral control is still unclear, although the release of B-endorphin and ACTH from the pituitary has been seen with acute stress. In addition, Chamberlain proposed that a second regulatory feedback loop may exist. This second loop involves the pineal gland, where secretion of melatonin and other opioids occur. " This axis includes an inhibitory effect of melatonin on CRH release from the hypothalamus which, in turn, inhibits the secretion of B-endorphin from the pituitary " (Chamberlain, 777). Furthermore, a study conducted by Dr. Lowenstein in 1984 showed that a feedback pathway exists where increased B-endorphin stimulates melatonin secretion. Dr. Chamberlain suggests that a breakdown in the functioning of either of these pathways may account for the psychiatric problems associated with autism. These various hormonal pathways offer possible biochemical etiology of autism. <!--See my SuperSig: http://proxy.supersig.com/sig?45002326_45002140--> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.